TransMedics Group, Inc. (TMDX) Free Cash Flow
TransMedics Group, Inc. (TMDX) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2019-12-31 | -$32.45M |
| 2020-12-31 | -$30.72M |
| 2021-12-31 | -$32.38M |
| 2022-12-31 | -$57.72M |
| 2023-12-31 | -$164.88M |
| 2024-12-31 | -$80.94M |
| 2025-12-31 | $133.59M |
How TMDX compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| VCYT | Veracyte Inc. | $126.63M |
| AMPH | Amphastar Pharmaceuticals Inc. | $118.98M |
| ICUI | ICU Medical Inc. | $82.83M |
| NTRA | Natera Inc. | $76.11M |
| RIGL | Rigel Pharmaceuticals Inc. | $75.66M |
These are five companies in the same sector as TMDX with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TransMedics Group, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("TMDX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMDX | $91.75 | -0.51% | 0.42M |
| 3 | ||||
| 4 | ||||
| 5 |